0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Imatinib Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-14Z6970
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Imatinib Drug Market Insights and Forecast to 2028
BUY CHAPTERS

Imatinib Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-14Z6970
Report
September 2024
Pages:119
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Imatinib Drug - Market Size

The global market for Imatinib Drug was estimated to be worth US$ 2781 million in 2023 and is forecast to a readjusted size of US$ 3621.8 million by 2030 with a CAGR of 3.8% during the forecast period 2024-2030

Imatinib Drug - Market

Imatinib Drug - Market

Imatinib is a chemotherapy drug that acts by reducing or preventing the progression of cancer cells. This drug is used for the treatment of certain cancers such as chronic myeloid leukemia, acute lymphoblastic leukemia, gastrointestinal tumors, certain skin tumors (dermatofibrosarcoma protuberans), and myelodysplastic/myeloproliferative diseases.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Imatinib Drug, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Imatinib Drug by region & country, by Type, and by Application.
The Imatinib Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Imatinib Drug.
Market Segmentation

Scope of Imatinib Drug - Market Report

Report Metric Details
Report Name Imatinib Drug - Market
Forecasted market size in 2030 US$ 3621.8 million
CAGR 3.8%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Novartis, Glenmark Pharmaceuticals Ltd., Sun Pharmaceuticals, Actavis Generics, Dr. Reddy's Laboratories, Teva Pharmaceutical Industries Ltd., Sanofi S.A., Cipla Inc., Apotex Inc., Mylan Pharms Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Imatinib Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Imatinib Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Imatinib Drug in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Imatinib Drug - Market size in 2030?

Ans: The Imatinib Drug - Market size in 2030 will be US$ 3621.8 million.

Who are the main players in the Imatinib Drug - Market report?

Ans: The main players in the Imatinib Drug - Market are Novartis, Glenmark Pharmaceuticals Ltd., Sun Pharmaceuticals, Actavis Generics, Dr. Reddy's Laboratories, Teva Pharmaceutical Industries Ltd., Sanofi S.A., Cipla Inc., Apotex Inc., Mylan Pharms Inc.

What are the Application segmentation covered in the Imatinib Drug - Market report?

Ans: The Applications covered in the Imatinib Drug - Market report are Chronic Myelogenous Leukemia, Gastrointestinal Stromal Tumors, Others

What are the Type segmentation covered in the Imatinib Drug - Market report?

Ans: The Types covered in the Imatinib Drug - Market report are Tablets, Capsules

Recommended Reports

Cancer Therapeutics

Prescription Medicines

Oncology Drugs

1 Market Overview
1.1 Imatinib Drug Product Introduction
1.2 Global Imatinib Drug Market Size Forecast
1.2.1 Global Imatinib Drug Sales Value (2019-2030)
1.2.2 Global Imatinib Drug Sales Volume (2019-2030)
1.2.3 Global Imatinib Drug Sales Price (2019-2030)
1.3 Imatinib Drug Market Trends & Drivers
1.3.1 Imatinib Drug Industry Trends
1.3.2 Imatinib Drug Market Drivers & Opportunity
1.3.3 Imatinib Drug Market Challenges
1.3.4 Imatinib Drug Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Imatinib Drug Players Revenue Ranking (2023)
2.2 Global Imatinib Drug Revenue by Company (2019-2024)
2.3 Global Imatinib Drug Players Sales Volume Ranking (2023)
2.4 Global Imatinib Drug Sales Volume by Company Players (2019-2024)
2.5 Global Imatinib Drug Average Price by Company (2019-2024)
2.6 Key Manufacturers Imatinib Drug Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Imatinib Drug Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Imatinib Drug
2.9 Imatinib Drug Market Competitive Analysis
2.9.1 Imatinib Drug Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Imatinib Drug Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Imatinib Drug as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Tablets
3.1.2 Capsules
3.2 Global Imatinib Drug Sales Value by Type
3.2.1 Global Imatinib Drug Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Imatinib Drug Sales Value, by Type (2019-2030)
3.2.3 Global Imatinib Drug Sales Value, by Type (%) (2019-2030)
3.3 Global Imatinib Drug Sales Volume by Type
3.3.1 Global Imatinib Drug Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Imatinib Drug Sales Volume, by Type (2019-2030)
3.3.3 Global Imatinib Drug Sales Volume, by Type (%) (2019-2030)
3.4 Global Imatinib Drug Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Chronic Myelogenous Leukemia
4.1.2 Gastrointestinal Stromal Tumors
4.1.3 Others
4.2 Global Imatinib Drug Sales Value by Application
4.2.1 Global Imatinib Drug Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Imatinib Drug Sales Value, by Application (2019-2030)
4.2.3 Global Imatinib Drug Sales Value, by Application (%) (2019-2030)
4.3 Global Imatinib Drug Sales Volume by Application
4.3.1 Global Imatinib Drug Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Imatinib Drug Sales Volume, by Application (2019-2030)
4.3.3 Global Imatinib Drug Sales Volume, by Application (%) (2019-2030)
4.4 Global Imatinib Drug Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Imatinib Drug Sales Value by Region
5.1.1 Global Imatinib Drug Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Imatinib Drug Sales Value by Region (2019-2024)
5.1.3 Global Imatinib Drug Sales Value by Region (2025-2030)
5.1.4 Global Imatinib Drug Sales Value by Region (%), (2019-2030)
5.2 Global Imatinib Drug Sales Volume by Region
5.2.1 Global Imatinib Drug Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Imatinib Drug Sales Volume by Region (2019-2024)
5.2.3 Global Imatinib Drug Sales Volume by Region (2025-2030)
5.2.4 Global Imatinib Drug Sales Volume by Region (%), (2019-2030)
5.3 Global Imatinib Drug Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Imatinib Drug Sales Value, 2019-2030
5.4.2 North America Imatinib Drug Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Imatinib Drug Sales Value, 2019-2030
5.5.2 Europe Imatinib Drug Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Imatinib Drug Sales Value, 2019-2030
5.6.2 Asia Pacific Imatinib Drug Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Imatinib Drug Sales Value, 2019-2030
5.7.2 South America Imatinib Drug Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Imatinib Drug Sales Value, 2019-2030
5.8.2 Middle East & Africa Imatinib Drug Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Imatinib Drug Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Imatinib Drug Sales Value
6.2.1 Key Countries/Regions Imatinib Drug Sales Value, 2019-2030
6.2.2 Key Countries/Regions Imatinib Drug Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Imatinib Drug Sales Value, 2019-2030
6.3.2 United States Imatinib Drug Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Imatinib Drug Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Imatinib Drug Sales Value, 2019-2030
6.4.2 Europe Imatinib Drug Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Imatinib Drug Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Imatinib Drug Sales Value, 2019-2030
6.5.2 China Imatinib Drug Sales Value by Type (%), 2023 VS 2030
6.5.3 China Imatinib Drug Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Imatinib Drug Sales Value, 2019-2030
6.6.2 Japan Imatinib Drug Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Imatinib Drug Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Imatinib Drug Sales Value, 2019-2030
6.7.2 South Korea Imatinib Drug Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Imatinib Drug Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Imatinib Drug Sales Value, 2019-2030
6.8.2 Southeast Asia Imatinib Drug Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Imatinib Drug Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Imatinib Drug Sales Value, 2019-2030
6.9.2 India Imatinib Drug Sales Value by Type (%), 2023 VS 2030
6.9.3 India Imatinib Drug Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Novartis
7.1.1 Novartis Company Information
7.1.2 Novartis Introduction and Business Overview
7.1.3 Novartis Imatinib Drug Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Novartis Imatinib Drug Product Offerings
7.1.5 Novartis Recent Development
7.2 Glenmark Pharmaceuticals Ltd.
7.2.1 Glenmark Pharmaceuticals Ltd. Company Information
7.2.2 Glenmark Pharmaceuticals Ltd. Introduction and Business Overview
7.2.3 Glenmark Pharmaceuticals Ltd. Imatinib Drug Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Glenmark Pharmaceuticals Ltd. Imatinib Drug Product Offerings
7.2.5 Glenmark Pharmaceuticals Ltd. Recent Development
7.3 Sun Pharmaceuticals
7.3.1 Sun Pharmaceuticals Company Information
7.3.2 Sun Pharmaceuticals Introduction and Business Overview
7.3.3 Sun Pharmaceuticals Imatinib Drug Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Sun Pharmaceuticals Imatinib Drug Product Offerings
7.3.5 Sun Pharmaceuticals Recent Development
7.4 Actavis Generics
7.4.1 Actavis Generics Company Information
7.4.2 Actavis Generics Introduction and Business Overview
7.4.3 Actavis Generics Imatinib Drug Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Actavis Generics Imatinib Drug Product Offerings
7.4.5 Actavis Generics Recent Development
7.5 Dr. Reddy's Laboratories
7.5.1 Dr. Reddy's Laboratories Company Information
7.5.2 Dr. Reddy's Laboratories Introduction and Business Overview
7.5.3 Dr. Reddy's Laboratories Imatinib Drug Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Dr. Reddy's Laboratories Imatinib Drug Product Offerings
7.5.5 Dr. Reddy's Laboratories Recent Development
7.6 Teva Pharmaceutical Industries Ltd.
7.6.1 Teva Pharmaceutical Industries Ltd. Company Information
7.6.2 Teva Pharmaceutical Industries Ltd. Introduction and Business Overview
7.6.3 Teva Pharmaceutical Industries Ltd. Imatinib Drug Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Teva Pharmaceutical Industries Ltd. Imatinib Drug Product Offerings
7.6.5 Teva Pharmaceutical Industries Ltd. Recent Development
7.7 Sanofi S.A.
7.7.1 Sanofi S.A. Company Information
7.7.2 Sanofi S.A. Introduction and Business Overview
7.7.3 Sanofi S.A. Imatinib Drug Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Sanofi S.A. Imatinib Drug Product Offerings
7.7.5 Sanofi S.A. Recent Development
7.8 Cipla Inc.
7.8.1 Cipla Inc. Company Information
7.8.2 Cipla Inc. Introduction and Business Overview
7.8.3 Cipla Inc. Imatinib Drug Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Cipla Inc. Imatinib Drug Product Offerings
7.8.5 Cipla Inc. Recent Development
7.9 Apotex Inc.
7.9.1 Apotex Inc. Company Information
7.9.2 Apotex Inc. Introduction and Business Overview
7.9.3 Apotex Inc. Imatinib Drug Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Apotex Inc. Imatinib Drug Product Offerings
7.9.5 Apotex Inc. Recent Development
7.10 Mylan Pharms Inc.
7.10.1 Mylan Pharms Inc. Company Information
7.10.2 Mylan Pharms Inc. Introduction and Business Overview
7.10.3 Mylan Pharms Inc. Imatinib Drug Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Mylan Pharms Inc. Imatinib Drug Product Offerings
7.10.5 Mylan Pharms Inc. Recent Development
8 Industry Chain Analysis
8.1 Imatinib Drug Industrial Chain
8.2 Imatinib Drug Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Imatinib Drug Sales Model
8.5.2 Sales Channel
8.5.3 Imatinib Drug Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Imatinib Drug Market Trends
    Table 2. Imatinib Drug Market Drivers & Opportunity
    Table 3. Imatinib Drug Market Challenges
    Table 4. Imatinib Drug Market Restraints
    Table 5. Global Imatinib Drug Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Imatinib Drug Revenue Market Share by Company (2019-2024)
    Table 7. Global Imatinib Drug Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Imatinib Drug Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Imatinib Drug Price by Company (2019-2024) & (USD/Unit)
    Table 10. Key Manufacturers Imatinib Drug Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Imatinib Drug Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Imatinib Drug
    Table 13. Global Imatinib Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Imatinib Drug as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Imatinib Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Imatinib Drug Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Imatinib Drug Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Imatinib Drug Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Imatinib Drug Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Imatinib Drug Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Imatinib Drug Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Imatinib Drug Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Imatinib Drug Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Imatinib Drug Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Imatinib Drug Price by Type (2019-2024) & (USD/Unit)
    Table 27. Global Imatinib Drug Price by Type (2025-2030) & (USD/Unit)
    Table 28. Global Imatinib Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Imatinib Drug Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Imatinib Drug Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Imatinib Drug Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Imatinib Drug Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Imatinib Drug Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Imatinib Drug Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Imatinib Drug Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Imatinib Drug Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Imatinib Drug Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Imatinib Drug Price by Application (2019-2024) & (USD/Unit)
    Table 39. Global Imatinib Drug Price by Application (2025-2030) & (USD/Unit)
    Table 40. Global Imatinib Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Imatinib Drug Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Imatinib Drug Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Imatinib Drug Sales Value by Region (2019-2024) & (%)
    Table 44. Global Imatinib Drug Sales Value by Region (2025-2030) & (%)
    Table 45. Global Imatinib Drug Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Imatinib Drug Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Imatinib Drug Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Imatinib Drug Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Imatinib Drug Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Imatinib Drug Average Price by Region (2019-2024) & (USD/Unit)
    Table 51. Global Imatinib Drug Average Price by Region (2025-2030) & (USD/Unit)
    Table 52. Key Countries/Regions Imatinib Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Imatinib Drug Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Imatinib Drug Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Imatinib Drug Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Imatinib Drug Sales Volume, (2025-2030) & (K Units)
    Table 57. Novartis Company Information
    Table 58. Novartis Introduction and Business Overview
    Table 59. Novartis Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 60. Novartis Imatinib Drug Product Offerings
    Table 61. Novartis Recent Development
    Table 62. Glenmark Pharmaceuticals Ltd. Company Information
    Table 63. Glenmark Pharmaceuticals Ltd. Introduction and Business Overview
    Table 64. Glenmark Pharmaceuticals Ltd. Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 65. Glenmark Pharmaceuticals Ltd. Imatinib Drug Product Offerings
    Table 66. Glenmark Pharmaceuticals Ltd. Recent Development
    Table 67. Sun Pharmaceuticals Company Information
    Table 68. Sun Pharmaceuticals Introduction and Business Overview
    Table 69. Sun Pharmaceuticals Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 70. Sun Pharmaceuticals Imatinib Drug Product Offerings
    Table 71. Sun Pharmaceuticals Recent Development
    Table 72. Actavis Generics Company Information
    Table 73. Actavis Generics Introduction and Business Overview
    Table 74. Actavis Generics Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 75. Actavis Generics Imatinib Drug Product Offerings
    Table 76. Actavis Generics Recent Development
    Table 77. Dr. Reddy's Laboratories Company Information
    Table 78. Dr. Reddy's Laboratories Introduction and Business Overview
    Table 79. Dr. Reddy's Laboratories Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 80. Dr. Reddy's Laboratories Imatinib Drug Product Offerings
    Table 81. Dr. Reddy's Laboratories Recent Development
    Table 82. Teva Pharmaceutical Industries Ltd. Company Information
    Table 83. Teva Pharmaceutical Industries Ltd. Introduction and Business Overview
    Table 84. Teva Pharmaceutical Industries Ltd. Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 85. Teva Pharmaceutical Industries Ltd. Imatinib Drug Product Offerings
    Table 86. Teva Pharmaceutical Industries Ltd. Recent Development
    Table 87. Sanofi S.A. Company Information
    Table 88. Sanofi S.A. Introduction and Business Overview
    Table 89. Sanofi S.A. Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 90. Sanofi S.A. Imatinib Drug Product Offerings
    Table 91. Sanofi S.A. Recent Development
    Table 92. Cipla Inc. Company Information
    Table 93. Cipla Inc. Introduction and Business Overview
    Table 94. Cipla Inc. Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 95. Cipla Inc. Imatinib Drug Product Offerings
    Table 96. Cipla Inc. Recent Development
    Table 97. Apotex Inc. Company Information
    Table 98. Apotex Inc. Introduction and Business Overview
    Table 99. Apotex Inc. Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 100. Apotex Inc. Imatinib Drug Product Offerings
    Table 101. Apotex Inc. Recent Development
    Table 102. Mylan Pharms Inc. Company Information
    Table 103. Mylan Pharms Inc. Introduction and Business Overview
    Table 104. Mylan Pharms Inc. Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 105. Mylan Pharms Inc. Imatinib Drug Product Offerings
    Table 106. Mylan Pharms Inc. Recent Development
    Table 107. Key Raw Materials Lists
    Table 108. Raw Materials Key Suppliers Lists
    Table 109. Imatinib Drug Downstream Customers
    Table 110. Imatinib Drug Distributors List
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Imatinib Drug Product Picture
    Figure 2. Global Imatinib Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Imatinib Drug Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Imatinib Drug Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Imatinib Drug Sales Price (2019-2030) & (USD/Unit)
    Figure 6. Imatinib Drug Report Years Considered
    Figure 7. Global Imatinib Drug Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Imatinib Drug Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Imatinib Drug Revenue in 2023
    Figure 10. Imatinib Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Tablets Picture
    Figure 12. Capsules Picture
    Figure 13. Global Imatinib Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Imatinib Drug Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Imatinib Drug Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global Imatinib Drug Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Imatinib Drug Price by Type (2019-2030) & (USD/Unit)
    Figure 18. Product Picture of Chronic Myelogenous Leukemia
    Figure 19. Product Picture of Gastrointestinal Stromal Tumors
    Figure 20. Product Picture of Others
    Figure 21. Global Imatinib Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global Imatinib Drug Sales Value Market Share by Application, 2023 & 2030
    Figure 23. Global Imatinib Drug Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 24. Global Imatinib Drug Sales Volume Market Share by Application, 2023 & 2030
    Figure 25. Global Imatinib Drug Price by Application (2019-2030) & (USD/Unit)
    Figure 26. North America Imatinib Drug Sales Value (2019-2030) & (US$ Million)
    Figure 27. North America Imatinib Drug Sales Value by Country (%), 2023 VS 2030
    Figure 28. Europe Imatinib Drug Sales Value (2019-2030) & (US$ Million)
    Figure 29. Europe Imatinib Drug Sales Value by Country (%), 2023 VS 2030
    Figure 30. Asia Pacific Imatinib Drug Sales Value (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Imatinib Drug Sales Value by Country (%), 2023 VS 2030
    Figure 32. South America Imatinib Drug Sales Value (2019-2030) & (US$ Million)
    Figure 33. South America Imatinib Drug Sales Value by Country (%), 2023 VS 2030
    Figure 34. Middle East & Africa Imatinib Drug Sales Value (2019-2030) & (US$ Million)
    Figure 35. Middle East & Africa Imatinib Drug Sales Value by Country (%), 2023 VS 2030
    Figure 36. Key Countries/Regions Imatinib Drug Sales Value (%), (2019-2030)
    Figure 37. Key Countries/Regions Imatinib Drug Sales Volume (%), (2019-2030)
    Figure 38. United States Imatinib Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 39. United States Imatinib Drug Sales Value by Type (%), 2023 VS 2030
    Figure 40. United States Imatinib Drug Sales Value by Application (%), 2023 VS 2030
    Figure 41. Europe Imatinib Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Europe Imatinib Drug Sales Value by Type (%), 2023 VS 2030
    Figure 43. Europe Imatinib Drug Sales Value by Application (%), 2023 VS 2030
    Figure 44. China Imatinib Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 45. China Imatinib Drug Sales Value by Type (%), 2023 VS 2030
    Figure 46. China Imatinib Drug Sales Value by Application (%), 2023 VS 2030
    Figure 47. Japan Imatinib Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Japan Imatinib Drug Sales Value by Type (%), 2023 VS 2030
    Figure 49. Japan Imatinib Drug Sales Value by Application (%), 2023 VS 2030
    Figure 50. South Korea Imatinib Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 51. South Korea Imatinib Drug Sales Value by Type (%), 2023 VS 2030
    Figure 52. South Korea Imatinib Drug Sales Value by Application (%), 2023 VS 2030
    Figure 53. Southeast Asia Imatinib Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 54. Southeast Asia Imatinib Drug Sales Value by Type (%), 2023 VS 2030
    Figure 55. Southeast Asia Imatinib Drug Sales Value by Application (%), 2023 VS 2030
    Figure 56. India Imatinib Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 57. India Imatinib Drug Sales Value by Type (%), 2023 VS 2030
    Figure 58. India Imatinib Drug Sales Value by Application (%), 2023 VS 2030
    Figure 59. Imatinib Drug Industrial Chain
    Figure 60. Imatinib Drug Manufacturing Cost Structure
    Figure 61. Channels of Distribution (Direct Sales, and Distribution)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS